Navigation Links
Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes
Date:4/4/2012

DECATUR, Ill., April 4, 2012 /PRNewswire/ -- Archer Daniels Midland Company (NYSE: ADM) is pleased to share the results of a new meta-analysis on the effects of soy isoflavones in the alleviation of menopausal hot flashes. The analysis, which was published March 19 by Menopause: The Journal of The North American Menopause Society, found clear and consistent evidence that soy isoflavone supplements, like NovaSoy brand soy isoflavones, are significantly more effective than placebo in reducing the frequency and severity of hot flashes.

"The key finding in this study is that when you limit the analysis to isoflavone supplements derived from soy or those with profiles identical to soy, there is a very consistent effect on hot flash relief," said Mindy S. Kurzer, Ph.D, professor of nutrition at the University of Minnesota, hormone expert and contributing author to the study. "Almost all studies in the meta-analysis show a consistent reduction in hot flash frequency and severity."

The meta-analysis – which is the largest and most comprehensive conducted to date – revealed that ingestion of soy isoflavones for six weeks to 12 months significantly reduced the frequency of hot flashes by more than 20 percent compared with placebo. Soy isoflavones also significantly reduced hot flash severity by more than 26 percent compared with placebo. The analysis found that the decrease in hot flash frequency in longer duration trials (more than 12 weeks) was approximately threefold greater than the decrease in shorter-duration trials.

"For women who are bothered by hot flashes, any reduction in frequency or severity may be welcome – especially if it can be achieved without side effects," said Melissa K. Melby, Ph.D (University of Delaware), hot flash expert and contributing author to the study. "Soy isoflavones appear to be a good first approach to alleviating hot flashes. Since there is often a large placebo effect, women taking supplements with the right soy isoflavone profile will likely see at least a 50 percent reduction compared to doing nothing."

Though many different isoflavones exist in nature, the three found in soy are genistein, daidzein and glycitein. According to the authors of the study, isoflavone supplements providing higher amounts of genistein were approximately 50 to 200 percent more potent at reducing hot flash frequency than isoflavone supplements containing lower amounts of genistein.

"Supplements providing a total of 50 mg of total isoflavones will be effective as long as they also provide at least 19 milligrams of genistein," said Mark Messina, Ph.D, soy expert, industry consultant and contributing author to the study.

"We are pleased that such a thorough evaluation of the most well-conducted studies showed that soy isoflavones are highly effective for the alleviation of hot flashes," said Steve O'Brien, product manager of Natural Health and Nutrition at ADM. "To maximize relief, ADM's NovaSoy brand soy isoflavones reflect the same profile of isoflavones naturally present in soy, including higher amounts of genistein."

"Hot flashes are one of the most common symptoms of menopause," added Messina. "For women with moderate-to-severe hot flashes who are seeking relief from symptoms, the reduction in the number and severity of hot flashes observed in our analysis in response to soy isoflavones will likely result in a significant improvement in quality of life."

A meta-analysis is a statistical analysis of a large number of studies for the purpose of integrating the findings. Of the 17 studies included in the meta-analyses, 13 trials (including 1,196 women) evaluated hot flash frequency, and nine trials (including 988 women) evaluated hot flash severity.

The analysis was conducted by Kyoko Taku, Ph.D, MD (National Institutes of Health, Japan); Melby; Fredi Kronenberg, Ph.D (Stanford University); Kurzer; and Messina. The complete article will be published in the July issue of Menopause.

NovaSoy brand products are available in drug, grocery, and health and nutrition stores and easily identifiable by the distinctive leaf logo. For more information about NovaSoy, including a list of products that contain NovaSoy, please visit www.NovaSoy.com.

About ADM

For more than a century, the people of Archer Daniels Midland Company (NYSE: ADM) have transformed crops into products that serve vital needs. Today, 30,000 ADM employees around the globe convert oilseeds, corn, wheat and cocoa into products for food, animal feed, chemical and energy uses. With more than 265 processing plants, 400 crop procurement facilities, and the world's premier crop transportation network, ADM helps connect the harvest to the home in more than 160 countries. For more information about ADM and its products, visit www.adm.com.

Archer Daniels Midland Company

Media Relations
Jessie McKinney
media@adm.com
217-424-5413

To schedule an interview with one of the research authors, contact:

Kristen Fraser
kfraser@stephanbrady.com
608-241-4141 ext. 229


'/>"/>
SOURCE Archer Daniels Midland Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
(Date:5/22/2017)... 2017  Lilac Corp, the company that sells ... of a new website . The website ... clinical study that showed surprising clearance of the ... individuals suffering from HPV warts, precancerous, or cancerous ... no other treatments that clear the virus. Specifically, ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... David B. Sosin, a founding partner at ... over the post of 2nd Vice President for the Illinois State Bar Association , ... the ISBA’s 3rd Vice President in 2016 following a state-wide election and served in that ...
(Date:6/28/2017)... , ... June 28, 2017 , ... American Farmer proudly ... episode of the award winning television series, scheduled to broadcast fourth quarter 2017. American ... originated as a regional supplier of garden pea seed. As demand grew, the small ...
(Date:6/28/2017)... Columbia (PRWEB) , ... June 28, 2017 , ... ... (FSE: ZEON) is pleased to announce that a two year study conducted by ... Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As a ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, a ... access to insurance assistance and financial planning services, is announcing the commencement of ... in the region facing financial crisis. , Matthew 25: Ministries (M25M) is an ...
(Date:6/28/2017)... Cincinnati, OH (PRWEB) , ... June 28, 2017 ... ... and financial consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is ... help provide temporary lodgings for families with children receiving treatment in nearby hospitals. ...
Breaking Medicine News(10 mins):